EmVenio Research
  • Home
  • Who We Are
    • Our Story
    • Our Team
    • Careers
  • Who We Serve
    • Patients
    • Local Communities
    • Research Partners
    • Sponsors
  • What We Offer
    • Global Site Network
    • Mobile & Virtual Visits
    • Patient Engagement
    • Therapeutic Area Focus
  • Resources
    • Insights
    • Events
  • Contact
Select Page
Ripple Enterprise to be an integral part of EmVenio Research’s Decentralized Clinical Trial (DCT) Platform

Ripple Enterprise to be an integral part of EmVenio Research’s Decentralized Clinical Trial (DCT) Platform

by EmVenio | Sep 15, 2022 | Press Release

Agreement signed for Ripple Enterprise patient engagement software to be deployed by EmVenio Research, making decentralized trials rapid and scalable. ANN ARBOR, MI, AND DURHAM, NC, USA, September 15, 2022 /EINPresswire.com/ — Ripple Science, a digital clinical...
Next Entries »

Recent Posts

  • EmVenio team attends 2025 World Vaccine Congress
  • EmVenio Research wins Best Clinical Trial Company award at 2025 ViE Awards
  • Virtually tour our dedicated research sites within Prime Healthcare
  • The EmVenio and PCM Trials Team Attend SCOPE 2025
  • Efficient Study Start-Up: Best Practices from a Clinical Site Network – A Webinar Recap

Recent Comments

No comments to show.

Partner with us.



Email Us

contact@emvenio.com



call us

+1 (919) 364-0166



Our Location

500 E 8th Street
Denver, CO 80203


Privacy policy

  • Follow
  • Follow
  • Follow
  • Follow
Sign Up To Our Newsletter